{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:24:22Z","timestamp":1781123062092,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This study was funded by StaGen Co. Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s10038-018-0558-0","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T09:25:54Z","timestamp":1547112354000},"page":"351-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment of two mitochondrial disease patients with a combination of febuxostat and inosine that enhances cellular ATP"],"prefix":"10.1038","volume":"64","author":[{"given":"Naoyuki","family":"Kamatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-7487","authenticated-orcid":false,"given":"Akifumi","family":"Kushiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-2441","authenticated-orcid":false,"given":"Licht","family":"Toyo-oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Toyo-oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.15252\/emmm.201505079","volume":"7","author":"PF Chinnery","year":"2015","unstructured":"Chinnery PF. Mitochondrial disease in adults: what\u2019s old and what\u2019s new? EMBO Mol Med. 2015;7:1503\u201312.","journal-title":"EMBO Mol Med"},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/path.4809","volume":"241","author":"CL Alston","year":"2017","unstructured":"Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241:236\u201350.","journal-title":"J Pathol"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.6032\/gnam.41.171","volume":"41","author":"N Kamatani","year":"2017","unstructured":"Kamatani N, Hashimoto M, Sakurai K, Gokita K, Yoshihara J, Sekine M, et al. Clinical studies on changes in purine compounds in blood and urine by the simultaneous administration of febuxostat and inosine, or by single administration of each. Gout Nucl Acid Metab. 2017;41:171\u201381.","journal-title":"Gout Nucl Acid Metab"},{"key":"558_CR4","unstructured":"Garrett RH, Grisham CM. Biochemistry. 6th ed. Philadelphia: Saunders; 2016. p. 927\u201356."},{"key":"558_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.6032\/gnam.42.59","volume":"42","author":"N Kamatani","year":"2018","unstructured":"Kamatani N, Furihata K, Taniguchi A, Fukuuchi T, Yamaoka N, Kaneko K, et al. In vitro enhancement of ATP in human erythrocytes from a healthy subject and two patients with thalassemia and hemoglobinopathy. Gout Nucl Acid Metab. 2018;42:59\u201364.","journal-title":"Gout Nucl Acid Metab"},{"key":"558_CR6","doi-asserted-by":"publisher","first-page":"D1258","DOI":"10.1093\/nar\/gkv1001","volume":"44","author":"AC Smith","year":"2016","unstructured":"Smith AC, Robinson AJ. MitoMiner v3.1, an update on the mitochondrial proteomics database. Nucleic Acids Res. 2016;44:D1258\u201361.","journal-title":"Nucleic Acids Res"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012;22:1760\u201374.","journal-title":"Genome Res"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2009;106:14670\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta. 2014;1842:1219\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"558_CR10","doi-asserted-by":"publisher","unstructured":"Desler C, Lillenes MS, T\u00f8njum T, Rasmussen LJ. The role of mitochondrial dysfunction in the progression of Alzheimer\u2019s disease. Curr Med Chem. 2017 \n                    https:\/\/doi.org\/10.2174\/0929867324666170616110111\n                    \n                  .","DOI":"10.2174\/0929867324666170616110111"},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ana.410400417","volume":"40","author":"RH Swerdlow","year":"1996","unstructured":"Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, et al. Origin and functional consequences of the complex I defect in Parkinson\u2019s disease. Ann Neurol. 1996;40:663\u201371.","journal-title":"Ann Neurol"},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.0501559102","volume":"102","author":"KR Short","year":"2005","unstructured":"Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA. 2005;102:5618\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"558_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun N, Youle RJ, Finkel T. The Mitochondrial basis of aging. Mol Cell. 2016;61:654\u201366.","journal-title":"Mol Cell"},{"key":"558_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/brain\/aww300","volume":"140","author":"J Koch","year":"2017","unstructured":"Koch J, Mayr JA, Alhaddad B, Rauscher C, Bierau J, Kovacs-Nagy R, et al. CAD mutations and uridine-responsive epileptic encephalopathy. Brain. 2017;140:279\u201386.","journal-title":"Brain"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0558-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:06:58Z","timestamp":1684616818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-018-0558-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1038\/s10038-018-0558-0","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NK is employed by and owns stock of StaGen Co. Ltd. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}